<<

/ 577

Pharmacopoeias. In Eur. (see p.vii). Diphenhydramine Citrate (BANM, rINNM) There have been reports3,4 of rhabdomyolysis as an effect of oral Ph. Eur. 6.2 ( Maleate). A white to almost white, Benzhydramine Citrate; Citrato de difenhidramina; Diphénhy- diphenhydramine overdosage. The liberal application of a lotion crystalline powder. Slightly soluble in water; soluble in methyl containing diphenhydramine produced acute delirium with visu- dramine, Citrate de; Diphenhydramini Citras. . Protect from light. al and auditory hallucinations in a 9-year-old boy5 and similar Дифенгидрамина Цитрат Profile effects were seen in 3 children with varicella-zoster infection fol- C17H21NO,C6H8O7 = 447.5. lowing the topical application of diphenhydramine (2 of these Dimetindene maleate, an alkylamine derivative, is a sedating an- CAS — 88637-37-0. children also received oral diphenhydramine).6 tihistamine (p.561); it is mildly sedative and is reported to have ATC — D04AA32; R06AA02. 1. Köppel C, Tenczer J. Clinical symptomatology of diphenhy- mast-cell stabilising properties. It is used for the symptomatic re- ATC Vet — QD04AA32; QR06AA02. dramine overdose: an evaluation of 136 cases in 1982 to 1985. lief of allergic conditions including urticaria and angioedema Pharmacopoeias. In US. Clin Toxicol 1987; 25: 53–70. (p.565) and rhinitis (p.565), and in pruritic skin disorders (p.565). USP 31 (Diphenhydramine Citrate). Store in airtight containers. 2. Radovanovic D, et al. Dose-dependent toxicity of diphenhy- It is also used in compound preparations for the symptomatic dramine overdose. Hum Exp Toxicol 2000; 19: 489–95. Protect from light. treatment of coughs and the common cold (p.564). 3. Hampel G, et al. Myoglobinuric renal failure due to -in- duced rhabdomyolysis. Hum Toxicol 1983; 2: 197–203. Dimetindene maleate is given in an oral dose of 1 to 2 mg three Diphenhydramine Di(acefyllinate) (rINNM) 4. Haas CE, et al. Rhabdomyolysis and acute renal failure follow- times daily; modified-release preparations are also available. It ing an ethanol and diphenhydramine overdose. Ann Pharmaco- may also be given by the intravenous route. Dimetindene Benzhydramine Di(acefyllinate); Bietanautine; Di(acefilinato) de ther 2003; 37: 538–42. maleate is applied topically as a 0.1% gel or lotion although, as difenhidramina; Diphénhydramine Diacéfylline; Diphenhy- 5. Filloux F. Toxic encephalopathy caused by topically applied with other , there is a risk of sensitisation. It is used dramine Di(acephyllinate); Diphenhydramini Diacefyllinas. diphenhydramine. J Pediatr 1986; 108: 1018–20. 6. Chan CYJ, Wallander KA. Diphenhydramine toxicity in three in a strength of 0.025% in compound nasal preparations. Diphenhydramine bis(theophyllin-7-ylacetate). children with varicella-zoster infection. DICP Ann Pharmacoth- Preparations Дифенгидрамина Диацефиллинат er 1991; 25: 130–2. Proprietary Preparations (details are given in Part 3) C17H21NO,2C9H10N4O4 = 731.8. Porphyria. Diphenhydramine has been associated with acute Austria: Fenistil; Belg.: Fenistil; Cz.: Fenistil; Ger.: Fenistil; Gr.: Fenistil; CAS — 6888-11-5. attacks of porphyria and is considered unsafe in porphyric pa- Hung.: Fenistil; India: Foristal; Indon.: Fenistil; Israel: Fenistil; Ital.: Fenistil; ATC — D04AA32; R06AA02. tients. Neth.: Fenistil; Norw.: Fenistil†; Philipp.: Fenistil; Pol.: Fenistil; Port.: Fen- ATC Vet — QD04AA32; QR06AA02. istil; Neostil; Rus.: Fenistil (Фенистил); Spain: Fenistil; Switz.: Fenistil; Pregnancy. A pregnant woman who was receiving diphenhy- Thai.: Fenistil; Turk.: Fenistil; Venez.: Fenistil†. NOTE. The name has been applied both to diphenhy- dramine hydrochloride 150 mg daily for a pruritic rash gave birth Multi-ingredient: Arg.: Vibragel; Austria: Trimedil; Vibrocil; Belg.: Vi- dramine monoacefyllinate and to ethylbenzhydramine, an an- to an infant who developed diarrhoea and generalised tremulous- brocil; Braz.: Gripen; Trimedal; Cz.: Vibrocil; Ger.: Vibrocil†; Gr.: Vibrocil- timuscarinic formerly used in the symptomatic treatment of par- ness 5 days later.1 The delay in appearance of withdrawal symp- S; Hong Kong: Vibrocil†; Hung.: Otrivin Allergia; Vibrocil; Israel: Vibrocil; kinsonism. Ital.: Vibrocil; Pol.: Otrivin Allergy; Port.: Vibrocil; Rus.: Vibrocil toms was considered to be due to reduced activity of glucuronyl (Виброцил); S.Afr.: Vibrocil; Vibrocil-S; Switz.: Vibrocil. conjugating enzymes in the first few days of life. Diphenhydramine Hydrochloride (BANM, rINNM) For discussion of the use of antihistamines in pregnancy, includ- Benzhydramine Hydrochloride; Difenhidramin Hidroklorür; ing a suggestion of a relationship between inguinal hernia or gen- Difenhidramin-hidroklorid; Difenhidramino hidrochloridas; ito-urinary malformations and diphenhydramine exposure, see Mesilate (BANM, rINNM) Difenhydramiinihydrokloridi; Difenhydramin-hydrochlorid; Difen- p.563. See also under Interactions, below, for a report of perinatal Dimethothiazine Mesylate; Dimétotiazine, Mésilate de; Dimeto- hydraminhydroklorid; Difenhydraminy chlorowodorek; Dime- death possibly associated with temazepam and diphenhy- tiazini Mesilas; Fonazine Mesylate (USAN); IL-6302 (dimetotiazine); drolum; Diphénhydramine, chlorhydrate de; Diphenhydramini dramine. Mesilato de dimetotiazina; 8599-RP (dimetotiazine). 10-(2- hydrochloridum; Diphenhydraminium Chloride; Hidrocloruro 1. Parkin DE. Probable Benadryl withdrawal manifestations in a new-born infant. J Pediatr 1974; 85: 580. Dimethylaminopropyl)-NN-dimethylphenothiazine-2-sulphona- de difenhidramina. mide methanesulphonate. Дифенгидрамина Гидрохлорид Interactions Диметотиазина Мезилат C17H21NO,HCl = 291.8. As for the sedating antihistamines in general, p.563. C19H25N3O2S2,CH3SO3H = 487.7. CAS — 147-24-0. CAS — 7456-24-8 (dimetotiazine); 7455-39-2 (dimeto- ATC — D04AA32; R06AA02. Diphenhydramine inhibits the cytochrome P450 isoen- tiazine mesilate). ATC Vet — QD04AA32; QR06AA02. zyme CYP2D6 that is partly responsible for the metab- ATC — N02CX05. Pharmacopoeias. In Chin., Eur. (see p.vii), Jpn, and US. olism of some beta blockers including metoprolol and ATC Vet — QN02CX05. Jpn also includes Diphenhydramine Tannate. the venlafaxine. Ph. Eur. 6.2 (Diphenhydramine Hydrochloride). A white or al- 1 most white, crystalline powder. Very soluble in water; freely sol- Benzodiazepines. There has been a report suggesting that a H3C CH3 uble in alcohol. A 5% solution in water has a pH of 4.0 to 6.0. reduction in temazepam metabolism caused by diphenhy- N Protect from light. dramine may have contributed to perinatal death after ingestion USP 31 (Diphenhydramine Hydrochloride). A white, odourless, of these by the mother. O O crystalline powder. It slowly darkens on exposure to light. Solu- 1. Kargas GA, et al. Perinatal mortality due to interaction of CH3 diphenhydramine and temazepam. N Engl J Med 1985; 313: ble 1 in 1 of water, 1 in 2 of alcohol and of chloroform, and 1 in 1417–18. N S CH3 50 of acetone; very slightly soluble in ether and in benzene. Its N solutions are neutral to litmus. Store in airtight containers. Pro- Pharmacokinetics tect from light. Diphenhydramine hydrochloride is well absorbed CH S 3 Incompatibility. Diphenhydramine hydrochloride has been re- from the gastrointestinal tract, although high first-pass ported to be incompatible with amphotericin B, cefmetazole so- (dimetotiazine) dium, cefalotin sodium, sodium succinate, some metabolism appears to affect systemic availability. soluble barbiturates, some contrast media, and solutions of alka- Peak plasma concentrations are achieved about 1 to 4 Profile lis or strong acids. hours after oral doses. Diphenhydramine is widely dis- Dimetotiazine mesilate, a derivative, is a sedating tributed throughout the body including the CNS. It (p.561). It has been used for the symptomatic relief Adverse Effects and Precautions crosses the placenta and has been detected in breast of hypersensitivity reactions, in pruritic skin disorders, and in the As for the sedating antihistamines in general, p.561. management of headaches including . milk. Diphenhydramine is highly bound to plasma pro- Abuse. Reports of the abuse of diphenhydramine hydrochlo- teins. Metabolism is extensive. Diphenhydramine is Preparations ride. excreted mainly in the urine as metabolites; little is ex- Proprietary Preparations (details are given in Part 3) 1. Anonymous. Is there any evidence that Benylin syrup is addic- creted as unchanged drug. The elimination half-life has Indon.: Migristene; Mex.: Migristene. tive? BMJ 1979; 1: 459. 2. Smith SG, Davis WM. Nonmedical use of butorphanol and been reported to range from 2.4 to 9.3 hours. diphenhydramine. JAMA 1984; 252: 1010. 3. Feldman MD, Behar M. A case of massive diphenhydramine ◊ References. abuse and withdrawal from use of the drug. JAMA 1986; 255: 1. Glazko AJ, et al. Metabolic disposition of diphenhydramine. Diphenhydramine (BAN, rINN) 3119–20. Clin Pharmacol Ther 1974; 16: 1066–76. 2. Paton DM, Webster DR. Clinical pharmacokinetics of H -recep- Benzhydramine; Difenhidramina; Difenhydramiini; Difenhy- 4. de Nesnera AP. Diphenhydramine dependence: a need for aware- ness. J Clin Psychiatry 1996; 57: 136–7. tor antagonists (the antihistamines). Clin Pharmacokinet 1985; dramin; Diphénhydramine; Diphenhydraminum. 2-Benzhydry- 5. Dinndorf PA, et al. Risk of abuse of diphenhydramine in children 10: 477–97. (includes studies indicating a correlation between loxy-NN-dimethylethylamine. and adolescents with chronic illnesses. J Pediatr 1998; 133: plasma concentrations and both antihistaminic and sedative ef- 293–5. fects). Дифенгидрамин 3. Simons KJ, et al. Diphenhydramine: pharmacokinetics and phar- Extrapyramidal disorders. Reports of dystonic extrapyrami- C17H21NO = 255.4. macodynamics in elderly adults, young adults, and children. J CAS — 58-73-1. dal reactions to diphenhydramine. Clin Pharmacol 1990; 30: 665–71. 1. Lavenstein BL, Cantor FK. Acute dystonia: an unusual reaction 4. Scavone JM, et al. Pharmacokinetics and pharmacodynamics of ATC — D04AA32; R06AA02. to diphenhydramine. JAMA 1976; 236: 291. diphenhydramine 25 mg in young and elderly volunteers. J Clin ATC Vet — QD04AA32; QR06AA02. 2. Santora J, Rozek S. Diphenhydramine-induced dystonia. Clin Pharmacol 1998; 38: 603–9. Pharm 1989; 8: 471. 3. Roila F, et al. Diphenhydramine and acute dystonia. Ann Intern Uses and Administration Med 1989; 111: 92–3. CH3 Diphenhydramine, a monoethanolamine derivative, is Overdosage. In an evaluation of 136 cases, one fatal, of intox- a sedating antihistamine with antimuscarinic and pro- ication with diphenhydramine, the plasma concentration was N 1 nounced sedative properties. It is used for the sympto- O CH correlated with frequency or extent of symptoms. The most 3 common symptom was impaired consciousness; psychosis, sei- matic relief of allergic conditions including urticaria zures, antimuscarinic symptoms such as mydriasis, tachycardia, and angioedema (p.565), rhinitis (p.565) and conjunc- and tachyarrhythmias, and respiratory failure were also ob- tivitis (p.564), and in pruritic skin disorders (p.565). It served. The positive association between dose and frequency and severity of symptoms was confirmed in a more recent study;2 it is also used for its antiemetic properties in the treat- was also found that severe symptoms were more likely to occur ment of nausea and vomiting (p.564), particularly in Pharmacopoeias. In Jpn. when 1 g or more of diphenhydramine had been taken. the prevention and treatment of motion sickness (when The symbol † denotes a preparation no longer actively marketed The symbol ⊗ denotes a substance whose use may be restricted in certain sports (see p.vii)